National Research Corporation logo

National Research Corporation (NRC)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
21. 78
-0.16
-0.7293%
$
487.92M Market Cap
33.66 P/E Ratio
0.64% Div Yield
52,700 Volume
0 Eps
$ 21.94
Previous Close
Add Transaction
Day Range
21.49 22.28
Year Range
11.01 23
Want to track NRC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NRC closed today lower at $21.78, a decrease of -0.7293% from yesterday's close, completing a monthly increase of 0.7634% or $0.17. Over the past 12 months, NRC stock gained 16.16%.
NRC pays dividends to its shareholders, with the most recent payment made on Jul 10, 2026. The next estimated payment will be in In 2 months on Oct 10, 2026 for a total of $0.16.
The last earnings report, released on May 05, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

NRC Chart

People also search for

Tyra Biosciences, Inc.
$ 32.13
+1.645%
Stoke Therapeutics Inc.
$ 29.05
-0.2061%
MBX
MBX Biosciences, Inc.
$ 62.92
+7.8875%
Sarepta Therapeutics Inc.
$ 17.22
-0.058%
BLU
BELLUS Health Inc
$ 14.74
+0.0339%
Is NuScale's NRC Licensing Lead Its Biggest Competitive Advantage?

Is NuScale's NRC Licensing Lead Its Biggest Competitive Advantage?

SMR's dual NRC Part 52 approvals give it a licensing head start that could speed deployments for AI sites and industry.

Zacks | 1 month ago
NRC Health (NRC) Q1 2026 Earnings Call Transcript

NRC Health (NRC) Q1 2026 Earnings Call Transcript

NRC Health (NRC) Q1 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
NRC Health Surges 62% in a Year: Should You Buy the Stock?

NRC Health Surges 62% in a Year: Should You Buy the Stock?

Strong recurring revenues, rising AI adoption and alignment with value-based care trends position NRC to capitalize on growing demand for patient-centric healthcare solutions.

Zacks | 3 months ago

National Research Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
CE
Curtis Ellergodt Rothschild Investment LLC
63 $865.04 $1,384.44 $519.4 60.04%
Joseph Castro
Joseph Castro Nuveen LLC
27,564 $353,768.06 $602,549.04 $248,780.98 70.32%
Brian Baylis
Brian Baylis Bell Investment Advisors Inc.
47 $789.6 $1,030.86 $241.26 30.55%
Ashish Sharma
Ashish Sharma DGS Capital Management LLC
10,371 $194,663.67 $224,895.13 $30,231.46 15.53%
MC
Mike Clark Cassady Schiller Wealth Management LLC
42 $740.88 $908.88 $168 22.68%

National Research Corporation (NRC) FAQ

What is the stock price today?

The current price is $21.78.

On which exchange is it traded?

National Research Corporation is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is NRC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.64%.

What is its market cap?

As of today, the market cap is 487.92M.

Has National Research Corporation ever had a stock split?

No, there has never been a stock split.

National Research Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Trent Green CEO
NASDAQ (NGS) Exchange
637372202 CUSIP
US Country
368 Employees
10 Jul 2026 Last Dividend
- Last Split
10 Oct 1997 IPO Date

Overview

Founded in 1981 and based in Lincoln, Nebraska, National Research Corporation is a leader in delivering comprehensive analytics and insights designed to enhance both patient and employee experiences within the healthcare sector. The company's offerings span across critical areas such as patient experience, service recovery, care transitions, and employee engagement, among others. Its mission is to provide healthcare organizations with actionable information and analysis that support improvement initiatives, reputation management, and brand loyalty efforts. National Research Corporation's solutions cater to a wide array of needs, aligning with the goals of maximizing constituent satisfaction and organizational effectiveness in healthcare settings.

Products and Services

National Research Corporation's suite of products and services is meticulously crafted to address various facets of healthcare organization needs, with a focus on delivering actionable insights for improvement and strategic management. Key offerings include:

  • Analytics and Insights: These tools are designed to measure and enhance patient and employee experiences, offering a foundation for targeted interventions in service recovery and care transitions. By leveraging these insights, healthcare organizations can better understand and act on the complex dynamics affecting patient and employee satisfaction.
  • Marketing Solutions: Focused on elevating healthcare brands, these solutions track brand awareness, perception, and consistency. Competitor differentiators are assessed, and advanced segmentation tools are employed to discern community needs, preferences, and behaviors, enabling real-time competitive assessments.
  • Experience Solutions: This category includes tailored solutions aimed at improving patient experience and employee engagement, through health risk assessments, care transition tools, and other targeted improvement instruments. These services empower health organizations to deepen their understanding of and response to the experiences of their patients and staff.
  • Reputation Solutions: To bolster healthcare organizations' public image, these solutions facilitate the distribution of timely and relevant content that shapes consumer perceptions and informs decision-making. They are designed to ensure that the organization's narrative is positively reflected in the public domain.
  • Governance Solutions: Specifically designed for the boards of directors, executives, and physician leaders of not-for-profit hospitals and health systems, these services offer strategic oversight tools and resources. They support effective governance practices, ensuring that leadership is aligned with both mission and performance objectives.

Contact Information

Address: 1245 Q Street
Phone: 402 475 2525